Moderna Revenue decreased by 42.6% to $389.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 260.2%, from $108.00M to $389.00M. Over 3 years (FY 2021 to FY 2025), Revenue shows a downward trend with a -52.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth indicates successful market penetration, pricing power, or volume expansion, while a decline suggests weakening demand or competitive pressure.
This represents the total gross revenue generated from the sale of goods and services to customers, excluding any sales-...
The standard top-line revenue metric used across all public companies for financial reporting.
other_revenue_from_contract_with_customer_excluding_asse_0d5b70| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.62B | $4.62B | $4.62B | $3.36B | $5.08B | $1.86B | $344.00M | $1.83B | $2.81B | $167.00M | $241.00M | $1.86B | $966.00M | $108.00M | $142.00M | $1.02B | $678.00M | $389.00M |
| QoQ Change | — | +0.0% | +0.0% | -27.2% | +51.1% | -63.4% | -81.5% | +432.3% | +53.5% | -94.1% | +44.3% | +672.6% | -48.1% | -88.8% | +31.5% | +615.5% | -33.3% | -42.6% |
| YoY Change | — | — | — | -27.2% | +10.1% | — | — | -45.6% | -44.7% | -91.0% | -29.9% | +1.7% | -65.6% | -35.3% | -41.1% | -45.4% | -29.8% | +260.2% |